Compare Enveric Biosciences Inc (ENVB) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Advanced Drainage Systems Inc — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Advanced Drainage Systems Inc trades at $153.03 (market cap $11.59B). The key difference: Advanced Drainage Systems Inc is far larger — about 2178.6× Enveric Biosciences Inc's market cap, and Advanced Drainage Systems Inc pays a 0.53% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | WMS | |
|---|---|---|
Market Cap | $5.32M | $11.59B |
Sector | Health | Industrials |
52-Week High | $17.40 | $175.38 |
52-Week Low | $1.28 | $110.89 |
Enterprise Value | $408.82K | $13.16B |
Dividend Yield | — | 0.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
WMS trades at $151.04, up 2.32% today, with a bullish technical signal from moving averages. The company reported consistent earnings beats in recent quarters, with Q1 2026 EPS of $1.07 exceeding the $0.936 estimate. Revenue for 2025 was $2.90B, with a net income margin of 13.98%. Recent news includes a dividend increase and a scheduled Investor Day.
The outlook is supported by strong profitability and a consensus price target of $184.43, implying 22% upside. Risks include a recent Zacks Strong Sell rating and projected earnings decline in 2026. Investor sentiment is mixed, with 41% of analysts rating Buy but some institutional selling noted.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
